Sign In

Thomas Engels

Previously US GM and VP of Clinical and Medical Affairs at LimFlow SA (acquired by INARI Medical)

Thomas Engels is a highly accomplished medical device executive with exceptional leadership and team building skills. He has a strong track record of securing substantial financing from various investors and establishing solid relationships with clinical investigators. With extensive experience in clinical trial strategy and operational expertise in cardiology device markets, Thomas is a valuable asset in the healthcare industry. Thomas Engels holds an MBA from both Columbia Business School and the University of California, Berkeley, Haas School of Business. Additionally, he has a Project Management Certification from Stanford University and a BS in Zoology from Louisiana State University. Thomas Engels has held key roles in reputable organizations such as LimFlow SA, Claret Medical, Micell Technologies, InGeneron Incorporation, CardioKinetix Inc., Abbott Vascular, Guidant Corporation, and Covance, Inc, showcasing his diverse expertise and leadership in the medical device sector.

Highlights

Nov 2 · linkedin

I am honored to announce that we have entered into a definitive agreement to be acquired by Inari Medical.

I look forward to this next phase, knowing that their ability to bring a new therapy to fruition will allow us to save so many more limbs.

Feb 15 · linkedin

Headed home from Singapore with the Japanese CLTI All Stars headed home ready to perform TADV. It is extremely gratifying to know that patients in Japan will soon have a new alternative to major amputation. #clti #limflow #japan #promise #flowsocks

T
Add to my network

Location

San Jose, California, United States